Content area
Full text
A domestically produced rotavirus vaccine, ORV 116E, appears to be cost effective for the prevention of rotavirus infection in India, according to findings of a study published in PLOS One.
A dynamic simulation model of rotavirus transmission was used to evaluate the cost effectiveness and public health impact of universal vaccination with the 116E vaccine at 6, 10 and 14 weeks of age in infants in India, compared with no rotavirus vaccination, from an all-payer (public sector and family)...